XJPX
5821
Market cap314mUSD
Jul 10, Last price
3,355.00JPY
1D
2.13%
1Q
-23.31%
Jan 2017
160.28%
IPO
253.16%
Name
Hirakawa Hewtech Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hirakawa Hewtech Corp., headquartered in Tokyo, Japan, was established in 1948, operating initially as Hirakawa Electric Wire Corporation before adopting its current name in October 1990. The company engages in the global manufacturing and distribution of a diverse range of cables, electronic equipment, and medical devices. Its extensive product lineup includes highly specialized super-fine coaxial cables for precise medical instruments, board-in cables for mounting applications, and wire harnesses crucial for internal and inter-machine wiring in multimedia and industrial apparatus. They also provide digital interface cables for signal transmission, Infiniband cables facilitating connections between servers and storage, and durable factory automation cables designed for industrial machinery like robots and machine tools. Additionally, their offerings encompass LCD cables for connecting notebook computer displays to main boards, and various broadcasting cables, such as optical camera cables and HC-4E6 microphone cords. Beyond cabling, Hirakawa Hewtech supplies flexible and power cords, power supply components, EMI shielding products, and broadcast and network solutions. A key area of its business involves the development, production, and sale of specialized medical tubing and related processed goods, serving the medical, analysis equipment, and other niche industrial sectors. Furthermore, the company offers comprehensive design, execution, and management services for electrical and telecommunications projects, alongside its activities in real estate leasing and management.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||